187 related articles for article (PubMed ID: 29151964)
1. ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.
Li R; Zhuang C; Jiang S; Du N; Zhao W; Tu L; Cao H; Zhang Z; Chen X
J Cancer; 2017; 8(18):3764-3773. PubMed ID: 29151964
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial-mesenchymal transition.
Wang Z; Fu L; Zhang J; Ge Y; Guo C; Wang R; Deng M; Wang Q; Wang Z
Biomed Eng Online; 2022 May; 21(1):30. PubMed ID: 35596183
[TBL] [Abstract][Full Text] [Related]
3. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
[TBL] [Abstract][Full Text] [Related]
4. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
Li W; Li S; Yang J; Cui C; Yu M; Zhang Y
Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876
[No Abstract] [Full Text] [Related]
5. Regulatory Mechanism of ITGBL1 in the Metastasis of Colorectal Cancer.
Qi L; Song F; Ding Y
Front Oncol; 2020; 10():259. PubMed ID: 32211321
[TBL] [Abstract][Full Text] [Related]
6. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
[TBL] [Abstract][Full Text] [Related]
8. ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axis.
Shen K; Xia W; Wang K; Li J; Xu W; Liu H; Yang K; Zhu J; Wang J; Xi Q; Shi T; Li R
J Cell Mol Med; 2024 Feb; 28(4):e18113. PubMed ID: 38332530
[TBL] [Abstract][Full Text] [Related]
9. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
[TBL] [Abstract][Full Text] [Related]
10. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
11. Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer.
Jin Q; Ren Q; Chang X; Yu H; Jin X; Lu X; He N; Wang G
J Cancer; 2021; 12(12):3648-3659. PubMed ID: 33995640
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling.
Gan X; Liu Z; Tong B; Zhou J
Tumour Biol; 2016 Feb; 37(2):1663-9. PubMed ID: 26307393
[TBL] [Abstract][Full Text] [Related]
13. ITGBL1 promotes gastric cancer cell proliferation and invasion via Akt signal pathway.
Yin FY; Qi HP; Qiao H; Lv XH; Tan HH
Front Biosci (Landmark Ed); 2021 Jan; 26(4):682-691. PubMed ID: 33049688
[TBL] [Abstract][Full Text] [Related]
14. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
[TBL] [Abstract][Full Text] [Related]
16. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.
Song J; Yang P; Lu J
Cancer Biomark; 2020; 27(1):51-61. PubMed ID: 31683459
[TBL] [Abstract][Full Text] [Related]
18. TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis.
Liu F; He Y; Cao Q; Liu N; Zhang W
Dis Markers; 2016; 2016():2436518. PubMed ID: 27672238
[No Abstract] [Full Text] [Related]
19. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
20. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
